Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) (Non-HDL-C)

Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) is a comprehensive clinical lipid parameter representing the total cholesterol content of all potentially atherogenic, apolipoprotein B-containing lipoproteins, including low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and lipoprotein(a) (American Heart Association, 2024). It is mathematically derived by subtracting high-density lipoprotein (HDL) cholesterol from the total cholesterol level, effectively capturing the total 'atherogenic load' in the bloodstream (StatPearls, 2023). Clinically, Non-HDL-C is a robust predictor of cardiovascular risk, often providing a more comprehensive assessment than LDL-C alone, particularly in patients with hypertriglyceridemia, diabetes, or metabolic syndrome (NIH, 2022). While not a singular molecular target such as a specific enzyme or receptor, Non-HDL-C serves as a primary or secondary therapeutic goal for pharmacological interventions aimed at preventing atherosclerotic cardiovascular disease (ASCVD). Commonly utilized drugs such as statins, PCSK9 inhibitors, and ezetimibe lower Non-HDL-C by either inhibiting hepatic cholesterol synthesis or enhancing the clearance of these particles from the circulation (Journal of Clinical Lipidology, 2021). Reducing Non-HDL-C levels has been consistently shown to decrease the risk of major adverse cardiovascular events (MACE) in high-risk populations (PubMed, 2020).

Other names

Non-LDL cholesterolNon-HDL cholesterolAtherogenic cholesterolTotal non-HDL-CCalculated non-HDL cholesterol

Drugs lower Non-HDL cholesterol levels by inhibiting HMG-CoA reductase (Statins) or ATP citrate lyase (Bempedoic acid) to reduce hepatic synthesis, inhibiting the NPC1L1 transporter to block intestinal absorption (Ezetimibe), blocking PCSK9 to increase LDL receptor recycling (PCSK9 inhibitors and siRNA), or activating PPAR-alpha to reduce VLDL production and enhance triglyceride clearance (Fibrates).